Ambrx Competitors and Similar CompaniesClear all

Ambrx's competitors and similar companies include ProQR Therapeutics and Redpin Therapeutics.
Ambrx
Ambrx
Ambrx is a biopharmaceutical company that discovers and develops engineered precision biologics therapeutics using an expanded genetic code.
ProQR Therapeutics
ProQR Therapeutics
ProQR Therapeutics is a company that develops RNA therapies designed for patients suffering from genetic rare diseases.
Redpin Therapeutics
Redpin Therapeutics
Redpin Therapeutics is a gene therapy company providing cell therapies that address diseases of the nervous system.
Founding Date
Founding Date
2003
Founding Date
2012
Founding Date
2017
Type
Type
Public
Type
Public
Type
Private
Tags
Locations
Locations
San Diego, US HQ
Locations
Leiden, NL HQ
Cambridge, US
Locations
New York, US HQ
New York, US
Employees
Employees
70
Employees
166
Employees
2
Valuation ($)
Valuation ($)
1.8 b
Valuation ($)
281.8 m
Valuation ($)
N/A

Financial

Revenue (est.)
Revenue (est.)
$7.4m (FY, 2022)
Revenue (est.)
€15.9m (FY, 2025)
Revenue (est.)
N/A
Net income
Net income
($78m) (FY, 2022)
Net income
(€42.2m) (FY, 2025)
Net income
N/A

Funding

Total funding raised
Total funding raised
$ 347.9m
Total funding raised
$ 57.8m
Total funding raised
$ 17m
For sources of this data, please see the company profile

View Company Profiles

ProQR Therapeutics
HQ
Leiden, NL
Employees
166

ProQR Therapeutics is a company that develops RNA therapies designed for patients suffering from genetic rare diseases.

View company
Redpin Therapeutics
HQ
New York, US
Employees
2

Redpin Therapeutics is a gene therapy company providing cell therapies that address diseases of the nervous system.

View company